Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02083510 · ClinicalTrials.gov registry record · Early Phase 1
Apolipoprotein CIII Reduction Via Colchicine
A Early Phase 1 study, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT02083510: Completed Early Phase 1 study, sponsored by Scripps Translational Science Institute.
NCT02083510 is a Early Phase 1 study that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 5 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02083510, a Early Phase 1 study, has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The aim of this trial will be to determine an effect-size for the administration of chronic low-dose colchicine in the reduction of serum levels of triglycerides (TG), very-low density lipoproteins (VLDL), and apolipoprotein CIII (apoCIII) in human subjects over a period of 4-6 weeks.
Interventions
- DRUG Colchicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-05 |
| Phase | Early Phase 1 |
What the finished NCT02083510 record still lists
NCT02083510 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Colchicine is the first listed.
NCT02083510 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02083510 about?
NCT02083510 is a clinical study titled "Apolipoprotein CIII Reduction Via Colchicine". The aim of this trial will be to determine an effect-size for the administration of chronic low-dose colchicine in the reduction of serum levels of triglycerides (TG), very-low density lipoproteins (VLDL), and apolipoprotein CIII (apoCIII) in human subjects over a period of 4-6 weeks.
What is the current status of trial NCT02083510?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2014-02. Estimated completion is 2014-05.
What interventions are being tested in trial NCT02083510?
The interventions under investigation include: Colchicine (DRUG).
Who is sponsoring clinical trial NCT02083510?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02083510's enrollment target sits among peer trials
5 1888th of 2000 higher than 80 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia